Renal outcomes of SGLT2 inhibitors and GLP1 agonists in clinical practice
Sign Up to like & getrecommendations! Published in 2020 at "Nature Reviews Nephrology"
DOI: 10.1038/s41581-020-0312-7
Abstract: Clinical trials of sodium–glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP1) receptor agonists have shown beneficial effects of these agents on kidney outcomes in patients with type 2 diabetes mellitus. Two new cohort… read more here.
Keywords: sglt2 inhibitors; clinical practice; renal outcomes; outcomes sglt2 ... See more keywords